• Astellas Pharma average return on equity for 2023 was 9.82, a 20.03% decline from 2022.
• Astellas Pharma average return on equity for 2022 was 12.28, a 17.64% decline from 2021.
• Astellas Pharma average return on equity for 2021 was 14.91, a 6.81% decline from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.